Stockpolly
Search
IBIO · NASDAQ · Biotechnology

iBio (IBIO)

Developing AI-enabled antibodies for obesity and body composition.

$1.31
Pre-market−0.01 (−0.76%)
At close$1.32(+4.76%)
Watchlist

In millions of USD, except per-share figures

In millionsQ1 FY24Sep 2023Q2 FY24Dec 2023Q3 FY24Mar 2024Q4 FY24Jun 2024Q1 FY25Sep 2024Q2 FY25Dec 2024Q3 FY25Mar 2025Q4 FY25Jun 2025Q1 FY26Sep 2025Q2 FY26Dec 2025Q3 FY26Mar 2026Q4 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
5443455567611
Research & development221112234439
33323332355−2
General & administrative03303332355−2
Other expenses000000000−3−35
Operating income−5−4−4−3−4−4−5−5−6−7−60
001000000−2−20
Interest income000000000011
Interest expense000000000000
Other non-operating income00−1000000220
Income before tax−5−4−3−3−4−4−5−5−6−9−8−11
Net income from continuing operations−5−4−3−3−4−4−5−5−6−9−8−11
Discontinued operations−1−4−1−500000000
Net income−6−8−3−8−4−4−5−5−6−9−8−11
EPS, basic−$4.79−$4.42−$0.85−$0.90−$0.46−$0.48−$0.49−$0.31−$0.11−$0.09−$0.06−$0.06
EPS, diluted−$4.79−$4.42−$0.85−$0.90−$0.46−$0.48−$0.49−$0.31−$0.11−$0.09−$0.06−$0.06
Weighted average shares, basic12499910165399120104
Weighted average shares, diluted12499910165399120104
EBITDA−5−4−2−3−4−4−5−5−5−9−70
Depreciation & amortization000000000000
EBIT−5−4−3−3−4−4−5−5−6−9−80